Developing an Effective Therapeutic HPV Vaccine to Eradicate Large Tumors by Genetically Fusing Xcl1 and Incorporating IL-9 as Molecular Adjuvants
Background: Human papillomavirus (HPV) is a prevalent infection affecting both men and women, leading to various cytological lesions. Therapeutic vaccines mount a HPV-specific CD8+ cytotoxic T lymphocyte response, thus clearing HPV-infected cells. However, no therapeutic vaccines targeting HPV are c...
Saved in:
Main Authors: | Zhongjie Sun, Zhongyan Wu, Xuncheng Su |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-01-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/13/1/49 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The significant role of IL-15, IL-22, IL-37, and caspase 9 in polycystic ovary syndrome: A case-control study in a sample of Iraqi women
by: Noor A. Mohammed, et al.
Published: (2025-03-01) -
Effectiveness of HPV vaccination in reducing infection among young Brazilian women
by: Ana Carolina da Silva Santos, et al.
Published: (2025-01-01) -
A novel therapeutic multiepitope vaccine based on oncoprotein E6 and E7 of HPV 16 and 18: An in silico approach
by: Sari Eka Pratiwi, et al.
Published: (2024-09-01) -
Understanding cervical cancer, human papillomavirus (HPV), and HPV vaccine acceptance in college-going students: Institutional-based cross-sectional study from Bihar State
by: Ekta Krishna, et al.
Published: (2025-01-01) -
Immunogenicity of the 9-valent human papillomavirus vaccine: Post hoc analysis from five phase 3 studies
by: Anna R. Giuliano, et al.
Published: (2025-12-01)